PapiVax Biotech
Biotechnology Research • 
Nangang District, Taipei City, Taiwan, Province of China • 1-10 Employees
Company overview
| Headquarters | 台北市南港區研究院路一段130巷99號, 國家生技研究園區C棟C421, Taipei, 115, TW |
| Website | |
| NAICS | 541714 |
| Founded | 2013 |
| Employees | 1-10 |
| Socials |
Key Contact at PapiVax Biotech
Shih Yeh
Director Of Product Development
About PapiVax Biotech
PapiVax Biotech, Inc. (PBI) is a biotechnology company that intends to become a global leader in immunotherapy for chronic viral infections and related cancers through application of our state-of-the-art immunology and virology expertise, first to develop safe and effective treatments for human papillomavirus (HPV) infections and related cancers and then to expand application of our immunotherapy platforms against other chronic virus infection-related human cancers.
PapiVax Biotech revenue & valuation
| Annual revenue | $342,220 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $1,100,000 |
| Total funding | No funding |
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Employees by Department
PapiVax Biotech has 2 employees across 2 departments.
Departments
Number of employees
Funding Data
PapiVax Biotech has never raised funding before.
PapiVax Biotech Tech Stack
Discover the technologies and tools that power PapiVax Biotech's digital infrastructure, from frameworks to analytics platforms.
JavaScript libraries
Security
Performance
JavaScript libraries
JavaScript libraries
WordPress plugins
Programming languages
Hosting
Blogs
UI frameworks
SEO
United Kingdom
United States
South Africa
Frequently asked questions
4.8
40,000 users
